Search Results - "Kadia TM"

Case series: rhabdomyolysis in patients taking isocitrate dehydrogenase inhibitors for myelodysplastic syndrome and relapsed/refractory acute myeloid leukemia.

Authors: Herstein JE Marx KR Haddad FG et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 May; Vol. 67 (6), pp. 1424-1426. Date of Electronic Publication: 2026 Feb 02.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies.

Authors: Senapati J Croden J Garcia-Manero G et al.

Source: HemaSphere [Hemasphere] 2026 Feb 12; Vol. 10 (2), pp. e70317. Date of Electronic Publication: 2026 Feb 12 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Case Report: FIA plus venetoclax in a patient on hemodialysis.

Authors: Herstein JE Marx KR Savoy JM et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jan 15; Vol. 15, pp. 1740357. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML.

Authors: Fiskus W Mill CP Piel J et al.

Source: HemaSphere [Hemasphere] 2026 Jan 15; Vol. 10 (1), pp. e70289. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.

Authors: Azevedo RS Braish J Gener-Ricos G et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 220-224. Date of Electronic Publication: 2025 Oct 31.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Acute Promyelocytic Leukemia Presenting with Cranial Nerve Involvement and Clivus Mass.

Authors: Nanduri AC Ashraf F Hlaing SS et al.

Source: Acta haematologica [Acta Haematol] 2026; Vol. 149 (2), pp. 221-227. Date of Electronic Publication: 2025 Mar 29.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0141053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1421-9662 (Electronic) Linking ISSN: 00015792 NLM ISO Abbreviation: Acta Haematol Subsets: MEDLINE

Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia.

Authors: Arani N Rausch CR Geppner A et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Dec; Vol. 66 (14), pp. 2794-2798. Date of Electronic Publication: 2025 Oct 22.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemia.

Authors: Jen WY Croden J Almanza-Huante E et al.

Source: HemaSphere [Hemasphere] 2025 Oct 22; Vol. 9 (10), pp. e70214. Date of Electronic Publication: 2025 Oct 22 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL.

Authors: Short NJ Jabbour E Macaron W et al.

Source: Blood cancer journal [Blood Cancer J] 2025 Oct 21; Vol. 15 (1), pp. 169. Date of Electronic Publication: 2025 Oct 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Authors: Nguyen D Kantarjian HM Bidikian A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia.

Authors: Lee D Abu-Shihab Y Plas K et al.

Source: Leukemia [Leukemia] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

Authors: Issa GC Cuglievan B El Hajjar G et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun 11, pp. JCO2601159. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Authors: Fiskus W Mill CP Issa GC et al.

Source: Blood [Blood] 2026 Jun 04; Vol. 147 (23), pp. 2809-2820.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

The role of advanced molecular diagnostics in informing targeted therapies for AML.

Authors: Marvin-Peek J Loghavi S Issa GC et al.

Source: Human pathology [Hum Pathol] 2026 May 30, pp. 106179. Date of Electronic Publication: 2026 May 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: W B Saunders Country of Publication: United States NLM ID: 9421547 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8392 (Electronic) Linking ISSN: 00468177 NLM ISO Abbreviation: Hum Pathol Subsets: MEDLINE

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

Authors: Short NJ Kantarjian HM Daver NG et al.

Source: Blood advances [Blood Adv] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Authors: Marvin-Peek J DiNardo CD Loghavi S et al.

Source: Cancer [Cancer] 2026 May 15; Vol. 132 (10), pp. e70434.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Mutations in isocitrate dehydrogenase portend a poor prognosis in adult patients with acute lymphoblastic leukemia.

Authors: Goulart H Short NJ Borthakur G et al.

Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 3276-3280.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process

Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Authors: Montalban-Bravo G Wu C Rodriguez-Sevilla JJ et al.

Source: Blood cancer discovery [Blood Cancer Discov] 2026 May 05; Vol. 7 (3), pp. 414-430.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Authors: Swaminathan M Ferrajoli A Thompson PA et al.

Source: Blood cancer discovery [Blood Cancer Discov] 2026 May 05; Vol. 7 (3), pp. 431-440.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Development and validation of the predictive aplastic score system (PASS): a simplified tool to diagnose acquired aplastic anemia in adults.

Authors: Aleixo G Cheon H Zheng J et al.

Source: Leukemia [Leukemia] 2026 Apr 27. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE